John D. Sheppard

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Quan Dong Nguyen, Pauline T. Merrill, Glenn J. Jaffe et al. · The Lancet · 2016 · 483 citations · Full text

Rheumatology, Visual Ii, Inactive Non-infectious Uveitis +8

Ocular TRUST: Nationwide Antimicrobial Susceptibility Patterns in Ocular Isolates

Penny A. Asbell, Kathryn Colby, Sophie X. Deng et al. · American Journal of Ophthalmology · 2008 · 227 citations

Antimicrobial Susceptibility, Antibiotics, Antimicrobial Stewardship +6

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease

John D. Sheppard, Gail Torkildsen, John Lonsdale et al. · Ophthalmology · 2013 · 206 citations

Ocular Disease, Ophthalmology, Glaucoma +4

Ionic channels induced by surfactin in planar lipid bilayer membranes

John D. Sheppard, Catherine Jumarie, David G. Cooper et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1991 · 157 citations

Proteinlipid Interaction, Membrane Formation, Biochemistry +7

Latrine ownership as a protective factor in inflammatory trachoma in Egypt.

Paul Courtright, John D. Sheppard, Stephen S. Lane et al. · British Journal of Ophthalmology · 1991 · 120 citations · Full text

Protective Factor, Trachoma Prevalence, Environmental Health +12